Regulus Therapeutics Inc. buy SVB Leerink LLC
Start price
18.03.24
/
50%
€2.10
Target price
18.03.25
€5.51
Performance (%)
-26.19%
Price
24.07.24
€1.61
Summary
This prediction is currently active. The prediction for Regulus Therapeutics Inc. disappoints with a performance of -26.19%. This prediction currently runs until 18.03.25. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regulus Therapeutics Inc. | 4.545% | 4.545% |
| iShares Core DAX® | 0.039% | 0.567% |
| iShares Nasdaq 100 | -4.018% | -5.554% |
| iShares Nikkei 225® | -2.389% | -1.434% |
| iShares S&P 500 | -2.115% | -2.351% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $6.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat